期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 255, 期 1-2, 页码 1-7出版社
ELSEVIER
DOI: 10.1016/j.jneuroim.2012.10.008
关键词
PU-H71; HSP90 inhibitors; Glial activation; EAE; Astrocytes; Microglia
资金
- NIND [R01NS055337]
Ansamycins are very effective HSP90 inhibitors that showed significant beneficial effects in the treatment of EAE. However, their toxicity and poor stability in solution limit their clinical use. In the present study we have characterized the anti-inflammatory properties of a novel HSP90 inhibitor, PU-H71, and tested its effects in EAE. Our findings show that PU-H71 reduced lipopolysaccharide astrocyte activation but failed to reduce the inflammatory cytokine activation. In contrast to ansamycins, PU-H71 weakly affects EAE clinical course. In conclusion, although PU-H71 displayed some anti-inflammatory properties, it appeared in vivo less effective than the more toxic HSP90 inhibitors. (C) 2012 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据